Archive: June, 2017

 

 

Adherium Appoints New CEO to Drive Global Growth

9 June 2017:link here

Read more about Adherium Appoints New CEO to Drive Global Growth

Dr Michael S. Perry appointed Avita Medical CEO

US-based CEO aligns with Avita’s increasing US orientation with BARDA contract, completed Phase 3 trial, imminent PMA submission, and pending US approval & commercialization • Mike Perry former Novartis Executive...

Read more about Dr Michael S. Perry appointed Avita Medical CEO

AmpliPhi Biosciences Appoints Paul C. Grint, M.D. as Chief Executive Officer

SAN DIEGO--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation (NYSE MKT: APHB), a global leader in the development of therapies to treat drug-resistant infections using bacteriophage-based technology, announces the appointment of Paul C. Grint, M.D.

Read more about AmpliPhi Biosciences Appoints Paul C. Grint, M.D. as Chief Executive Officer

Avita Medical’s Board show confidence in company by taking payment in shares

Directors take up to 100 per cent of fees in shares • Follows shareholder approval of employee share plan in November last year Northridge, CA, USA, Perth, Australia and Cambridge,...

Read more about Avita Medical’s Board show confidence in company by taking payment in shares